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ml Identification of Nocardia genus by PCR 
F. Laurent',', P. Boiron'. Instirut Pasteirr, LJrLit q f A 4 y c o l o ~ f ~  Paris, 
'Lab07dtor)J of BactCriology, Hospices Civils de Lyon, Lyon, France 
The conventional identification of strains belonging to actinoniycetes 
is based on chemotaxonoinic characteristics. However, these tech- 
niques are laborious, time-consuming, and expensive; they can take 
1-3 weeks to accomplish and are sometimes not able to fully differen- 
tiate some of the most closely related strains. Two regions of the gene 
coding for 16s rKNA in Norardia species were selected as genus- 
specific primer sequences for a P C R  assay. The PCR protocol was 
tested with 60 strains of clinically relevant Nocardia isolates and type 
strains. It gave positive results for all strains tested. Conversely, the 
PCR assay was negative for all tested species (n=70) belonging to the 
most closely related genera, including Dietzia, Gordona, Myco- 
bacterium, Rhodococcus, Streptomyces, and Tsukamurella. Besides, unlike 
the latter group of isolates, all Nocardia strains exhibited one MInI 
recognition site but no Sad restriction site. This assay offers a novel 
specific and rapid (less than 2 days) alternative to chemotaxonomic 
methods for identification of Nocardia spp. isolated from pathogenic 
samples. It would improve the speed of diagnosis, which is closely 
related to the favorable evolution of the patienti condition (mortality, 
relapses and after-effects). At present, we are performing an extensive 
study of the use of this PCK technique directly with clinical samples. 
Rapid detection of toxigenic Clostridium 
difficile from stool samples by a nested PCR of 
toxin B gene 
R. Alonso, C. Munoz, S. Gross, D. Garcia de Viednia, T. Pelaez, 
M. Rodriguez-Creixems, E. Bouza, Hospital Greprio Maranon, 
Microbiolgia, Madrid, Spaitr 
Introduction: Toxigenic Clostridium dijficile is the etiologic cause of 
most cases of antibiotic-associated diarrhea. The present standard 
method for C. d@ri/e detection is a cytotoxicity assay performed on 
human fibroblasts which is time-consuming and requires special 
facilities 
Objective: To develop a nested P C R  assay for the detection of 
toxigenic strains of C. d@ci/e directly from clinical stool samples 
Materials and methods: One hundred and two stool samples, 
submitted to our laboratory for C. dlfFn'/e investigation, were in- 
cluded. All samples were cultured on CCFA, toxicity was tested on 
fibroblasts and all were processed by PCR. Samples were prepared for 
PCR following a commercial extraction system (QIAmp Tissue Kit, 
QIAGEN, USA). Primers CDTBI (GTG GCC CTG AAG CAT 
ATG), CDTB? (TCC TCT C T C  TGA ACT T C T  TGC) and 
CDTB3 (GCT TCT TCA ATC C T T  T C C  TC) were used for 
amplifications. All samples included an internal control to check for 
potential inhibitions 
Results: Twenty-seven samples (26.5%) carried toxigenic C. 
d$ficik strains, while the remaining 75 (73.5%) did not carry the 
microorganism. The agreement between cytotoxicity and the P C R  
assay was 99% Sensitivity, specificity, and positive and negative 
predictive values of the PCR versus cytotoxicity assay were 96.3%, 
100%. 100% and 98.7% respectively. Inhibition was observed in 0.9% 
of the samples. The procedure is fast (about 4 h), easy to perform and 
correlates very well with the present reference method 
Conclusions: Direct PCR may be an option for detecting C. 
d@ci/e directly from stool samples, especially for laboratories lacking 
tissue-culture facilities 
Methicillin-resistant Staphylococcus aureus 
(MRSA)/Vancomycin-resistant enterococci 
(VRE) 
ml In vivo horizontal transfer of the mecA 
determinant conferring methicillin resistance 
C.L.C. Wielders, E.D.J. Peeters, A.T.A. Box, C.A.M. Miltenburg, 
A. Troelstra, A. Fleer, F.J. Schmitz, J.Verhoef, A.C. Fluit. 
Eijkman- CVirzkler Institute, University Hosp. Utrecht, The  Netherlands 
Introduction: The use of oxacillin results in ongoing selection for 
methicillin-resistant Staphylococcus aimus (MRSA) strains. Here we 
report evidence for the in vivo transfer of the mccA determinant, 
which is implicated in rnethicillin resistance, to S. aureirs 
Results: Afcer 3 weeks of antibiotic therapy to treat an initial 
(non-MRSA) staphylococcal infection, an MRSA-positive blood 
sample was obtained from a neonate carrying an infected thorax 
canula. These successive infective isolates shared an uncommon 
phage type. Comparison of Smal-generated restriction fragment 
length (PFGE) patterns revealed a single bandshift, resulting from 
incorporation of a 40-kb fragment that hybridized with a niecA probe. 
This indicates that horizontal transfer of the mecA DNA that confers 
resistance to niethicillin did occur in the presence of selective anti- 
biotic pressure in vivo. Several mecA+ coagulase-negative staphylo- 
coccal species could be isolated from the child as a potential source 
for the merA DNA. In addition, an MSSA producing a 6-lactamase 
with a phage and PFGE type identical to those of the initial MSA 
isolate could be cultured. --Lactamase-carrying plasmids are impli- 
cated in the stability and expression of the mecA region. From the 
father of the neonate, a non---lactamase-producing MSSA strain of 
matching genotype was isolated 
Conclusion: These data suggest the evolution from --lactamase- 
negative MSSA, through -4actamase-producing MSSA, to MRSA 
in vivo 
Spread of methicillin-resistant clumping factor- 
negative (CF-) Staphylococcus aureus 
K. Trzcinski, J. Walory, S. Murchan, W. Hryniewicz. Sera and 
I'accines Central Rescarch Laboratory, CZ.hrsaw, Poland 
Objectives: To investigate the relatedness of 30 MRSA isolates from 
Poland, Hungary and Slovenia, identified as clumping factor negative 
(CF-) 
Methods: Identification of S. a~ueus was based on detection of 
free coagulase by tube test and precence of coagulase (coa) and protein 
A (spa) genes detected by PCR.  Relatedness among MRSA strains 
was evaluated by restriction fragment length polymorphism (RFLP) 
analysis of spa and coa genes, arbitrary primed (AP) PCR analysis of 
total DNA with AP-7 primer, and RFLP analysis of SmaI-digested 
chromosomal DNA following PFGE. Antimicrobial resistance 
patterns were evaluated using a set of 20 antimicrobial agents 
Results: All strains were CF- by slide agglutination test with rabbit 
plasma. Analysis of coa and SmaI RFLP revealed identical coo and 
closely related StnaI patterns for 17 of the 30 MRSA isolates from 
Hungary, Poland and Slovenia (cluster I ) .  Spa gene polymorphism 
analysis showed that all these isolates carried 10 or I 1  repetitive 
motifi. Only three isolates originating from a single center in Poland 
showed a different genotype clearly identified by roa and S n d  RFLP 
patterns (cluster 11). Almost all 27 genetically related isolates of cluster 
I showed similar patterns of resistance to ammoglycosldec, macro- 
lides, lincosamides, tetracyclines, rifampin and ciprofloxacin, whereas 
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the three MRSA isolates of cluster I1 were susceptible to all of these 
drugs 
Conclusion: The results of this study indicate a clonal spread of 
MKSA with a defect of C F  production in three different European 
countries. 
Wl Characterization of MRSA from Kuwait 
hospitals 
E.E. Udo, L.E. Jacob, R. Dhar, E.M. Mokadas, M. Johny. 
Dqiartnrerrt ofMirro/h/oCqy, Fatrrlty of Medicine, Krrtrmir L'triuersir),, 
Kuwait 
Objectives: To determine the clonality and genetic location of 
resistance deterniinants in MRSA isolates from sonie Kuwait 
hospitals 
Methods: Three hundred MKSA strains isolated froin different 
clinical saiiiples at four hospitals between 1994 and 1996 were typed 
by pulsed-field gel electrophoresit. Resistance to antimicrobial agents 
was determined by the di\k diffusion method. The genetic location 
of resistance deterniinants was determined by a combination of 
curing and trantfer experiments 
Results: All of the MKSA isolates were resistant to gentamicin, 
kanaiiiyciti and streptomycin. Ninety-four per cent and 93% were 
resistant to tetracycline and triniethoprin respectively. Forty per cent 
were reaistant to ciprofloxacin and 18% were resistant to fusidic acid. 
All were susceptible to vancomycin and teicoplanin. Resistance to 
erythromycin and chloraniphenicol was located on  small 3.0-4.4-kb 
plasmids. Resistance to cadiniuni, propainidine and ethidium 
bromide was located on 28-kb plasmids. Resistance to niethicillin, 
penicillin G, gentamicin, streptoniycin, ciprofloxacin, tetracycline, 
triniethoprini and fusidic acid was chromosomal. The majority of 
them belonged to two closely related pulsed-field patterns 
Conclusion: Two closely related epidemic MKSA clones were 
circulating in the four Kuwait hospitals and provided evidence for 
their inter-hospital transinitsion 
ml Interpretation criteria for pulsed-field gel 
electrophoresis (PFGE) typing of MRSA 
13s. Blanc, C. Petignat, PM.  Hauser, J. Bilk, N. Trolllet, 
I-! Francioli, Hosp. Uuivenitaire Vnirdoir, Division a i t f o i r ~ w ~ r  de iriedicirrr~, 
Larisarrric, Switzcrlurrd 
Objective: To establish interpretation criteria for PFGE typnig 
patterns of inethicillin-resistant Staphyl~irorcrrs aiirriis (MKSA) in the 
setting of nosocomial transniission 
Methods: PFGE analysit of Smu-digested DNA from MRSA 
isolates of long-teriii carriers and of well-defined MRSA epidemics 
Results: Ninety-three isolates from 42 patients harboring MRSA 
during a period ofmore than 1 month were analyzed. The first i\olate 
was compared to one or niore subsequent isolates. Out  of 46 pairs of 
isolates, seven (15%) were found to diffcr by two to six bands. In the 
24 pairs obtained less than 3 months apart, only two (8%) differed by 
two to six bands, and five of 22 (23%) of those obtained more than 
3 months apart. During the occurrence of three hospital epidemics, 
involving a total of 82 persons and lasting 2, 12 and 15 months, 
respectively, 106 isolates were analyzed and only one isolate difisred 
by four bands from the epidemic strain. One of the clones involved 
in two of thesr epidemics was also involved in other institutions of 
western Switzerland. Over A period of 3 years, 210 isolates of thls 
clone from 179 persons were analyzed; only 17 (8%) differed from 
the epidemic strain by two to six bands 
Conclusions: I'FGE patterns of MKSA are relativcly stdde over 
a period of weeks to months. Therefore, possible tran\mission of 
MItSA between patients hospitalized during the smie period should 
be considered only if PFGE patterns are indistinguishable. 
Enhanced efficacy of moxifloxacin against 
Staphylococcus aureus 
S.G.U. Amyes, E.J. Durhain, C.J. Thonison, A. IMhoff, I iiiiurniry 
of Ediribrryh, Mrdical ,tfi1-r06i11lo~q~ Edidriip+, CIK 
Moxifloxacin (BAY 12-8039) is a nem 8-iiiethoxyq~iiii~lone wmh 
enhanced activity against Gram-positive organisin\. The 
concentratioti-dependent killing activity m d  tinie-kill kinetic\ of 
nioxifloxacin dgainst standard and clinical \train\ of S r ~ i ~ ~ / i ~ ~ / ~ ~ ~ - ~ c r i r s  
aurrus were investigated. Moxifloxacin was rapidly bactericidd a t  1 .(I 
rng/L against laboratory and sensitive clinicd \trains (El17 .ind El", 
and bactericidal a t  2.0 mg/L or  above for ciprofloxacin-re\istant 
clinical strains (ED3 and EDS). In order to determine the preferred 
topoiyomerase target of nioxifloxacin in S. aiireiis. first-, second- and 
third-generation mutants were selected from the scnsirive strain 
N C T C  8323/4 and the quinolone resi\tance-determiiiiii~ region 
(QKDR)  of<qyrA a n d & 4  was sequenced. O n l y  one first-step mutant 
showed a change $11 GrlA (SerHO-l'he) but no other tirst-step 
niutations wei-e detected. Three different GyrA mutations conferring 
the same MIC were detected in second-yeneration niutaiits (SerX4 
to Ala or  Leu, and Glu88 to Lys). The combination of GyrA and 
GrlA mutations in two wains did not confer higher Ievel~ of 
resistance. All third-generation niutants conferred a GIuX4-Lys 
change in GrlA which increased the MIC to 85-00 times that of 
strain N C T C  8325/4. These results suggest that iii these strains 
topoiyoinerase IV is not the primary tarset of moxifloxacin i n  S. 
ourrrjs. In vivo studies thowed a clear dose rrspomr when 
moxifloxacin was used to treat subcutaneous staphylococcal ~ i b  
in mice. Not oiilv did the number of viable bacteria decrease 
significantly, but fewer resistant mutants were selected from tri..ited 
animals compared with the untreated controls; niutation frequencies 
decreased as the dose increated. 
1080) Extensive persistence of vancomycin-resistant 
enterococci on Norwegian poultry farms 3 
years after the avoparcin ban 
G.S. Sinionsen'-', K .  Uorgeii', G. Schaller', O. Olsvik',', 
Y. Wasteson', H. Kruse', A. Sundsfjord' I .  'Dqiarrrricvif i ~ f . t f d i i n l  
Mirrobio/i;qy, Sr/ioo/ of Mdicirre, L'uiviwify qf Troi~isv, 'Drparfiiiriit of 
Mirrobiolqyy, Iinii~crsiry Hcispiiuf ?f Troinso. 'The N~iriu~yiaii Srliiiol 4 
&teriirury Stiencr, O.F/II, ',b'utional b+terinnry Irzstitrrte, C h / o  i\clnuay 
Avoyarciii was used as a growth-promoting feed dditivc' in Nor- 
wegian broiler and turkey production from 1986 until it was banned 
in June 1995 due to :I strong association between this practice and 
the occurrence of VanA-type VancoiiiyCin-resistaiit enterococci 
(VRE). The  aim of our study was to Investigate the prevalence of 
VRE among Nonvcgian poultry and poultry farmer\ 3 years after 
avoparcin was banned 
The  study included 75 previously avoparcin-exposed f a r m  wlth 
broilers or turkeys and 77 control farnit producing e g g  or breeding 
chickens never exposed to avoparcln. Fecd material from poultry 
litter streaked on selective agar plates revealed VILE from 74 of 75 
previously avoparcin-exposed farms (98.7 'XI)  and from 7 of 74 
control farins (9.5'%, RR: 10.4; 95% CI: 5.2-21. I ) .  Fecal samples 
from one person at each firm grown in a selective enrichment broth 
contained VRE in 13 of 75 avoparcin-exposed farmers (1 7% 9S'%i 
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CI: 8.8-25.9%), compared to only 1 of 77 controls (1.3%). All VRE 
were of the VanA phenotype and possessed the vanA gene as shown 
by PCR 
The documented extensive persistence of VRE among humans 
and poultry on previously avoparcin-exposed farms in a glycopeptide- 
free environment indicates that the bacteria are well adapted to their 
VanA resistance determinants and carry them without a significant 
loss of fitness. The persistence ofVRE does not seem to be the result 
of traditional antibiotic co-selection, as the Norwegian poultry 
industry abandoned the use of antimicrobial feed additives in 1995. 
However, the u a r d  gene cluster is often carried on large conjugative 
plasmids encoding other functions that may be positively selected. We 
do not know if human and animal reservoirs persist separately or 
communicate by repeated interspecies transmission. 
1 Vancomycin-resistant enterococci in Scotland 
K.F. McGregor', R.R.S. Nelson', S.G.B. Amyes', H.-K. Young'. 
'Deparfment of Biological Srienccs, Utiiversity o f  Dundec, ZDepartment o f  
Clinical Microbiology, Western Infirmary, Clasgow, 'Departmefzt o f  
Medical Microbiology, University qf Edinburgh, UK 
Objectives: In 1996 a fecal screening program was commenced to 
isolate and subsequently characterize vancomycin-resistant entero- 
cocci in Glasgow 
Methods: All isolates were speciated by a combination of P C R  
and biochemical tests and tested for susceptibility to vancomycin, 
teicoplanin, ampicillin, tetracycline, streptomycin, gentamicin and 
ciprofloxacin. PCK analysis was performed to identify uanA, uanB 
and variC genes 
Results: Between February 1996 and April 1998, 107 isolates 
were collected by the screening program. The majority (87%) of 
isolates were VanB-producing Enterococcrus faecinm (VBEF). The 
remaining isolates consisted of two E. gallinamm (vanC-I), six E. 
fnecalis (uanA) and a further five E. faecium (4 uanA, 1 both uanA and 
vanB). During this time, 33 clinical isolates wete obtained from 
blood, urine and CAPD fluid of patients. These included 31 VBEF, 
one E. faecinm (uanA) and one E. g a h m u m  (uanc- 1 ) .  Resistance to 
high levels of aniinoglycosides and ciprofloxacin was seen in <5% of 
isolates. The VBEF isolates were almost uniformly resistant to 
ampicillin and tetracycline 
Conclusions: The predominant type of VRE in Glasgow are 
VanE-producing E.faecium. These findings differ from those of other 
studies in Europe, where the majority of strains carry u a d .  
I 082 I Epidemiology of vancomycin-resistant 
enterococci (VRE) colonizing high-risk patients 
in hospitals in Johannesburg, South Africa 
A. von Gottberg, W. van Nierop, A. Duse, M. Kassel, 
K. McCarthy, A. Brink, M. Meyers, K. Sniego, H. Koornhof. Irut. 
f o r  Med. Research, Diu. o f  Hospital Epidem., Jokannesbirrp, South Africa 
Recent cases of VRE infection have highlighted the emergence of 
these organisms in our country. Routine surveillance for VRE is not 
practiced in Johannesburg hospitals, and its epidemiology has not 
been previously described. In May 1998, we conducted a prevalence 
study of patients in four city hospitals, and obtained 184 rectal swabs 
from patients identified as high risk (located in intensive care, burn, 
renal dialysis, or oncology units). Using four different screening 
media, we isolated 20 enterococcal organisms showing varied resist- 
ance to vanconiycin: Enterococrusfaecium uanA (4 isolates), E.  fneciirm 
uanB (lo), and E. gallinanrm uanCl (6). Genotypes of these isolates 
were confirmed with PCK and correlated with phenotypic charac- 
teristics. Using macrorestriction analysis with pulsed-field gel electro- 
phoresis, the clonal spread of VRE strains within hospitals was 
demonstrated. The results also showed evidence of possible 
persistence of the original E. jkcium uanA associated with the first 
known death due to VRE infection in South Africa in the same ward 
where it had been isolated in March 1997. All four screening media 
performed adequately and three were chosen for continued 
surveillance of VRE colonization and infection in our hospitals. 
10831 Prevalence of IS256 insertion sequence in the 
genus Enterococcus 
G. Bamias', G. L. Daikos', H. Alexandrou', A. Pagali', 
G. Christakis', A. Katrahoura', V. Syriopoulou'. 'Sismano&on 
General Hospital, 'Agkia Sopkia Ckildrm 's Hospital, -'Athens 
Utiiuersity, and Metaxa Hospital, Atkens, Greece 
There is increasing evidence that IS256 insertion sequence is an 
independently mobile element involved in the dissemination of high- 
level aminoglycoside resistance (HLAK) in enterococci 
Objectives: To determine the prevalence of IS256 insertion 
element in the genus Enterococcus in our geographic region 
Methods/results: One hundred and forty-four clinical isolates of 
enterococci exhibiting polymorphic pulsed-field gel electrophoresis 
patterns were examined for the presence of IS256; 100 were E.faecalis 
(64 HLAR and 36 aminoglycoside susceptible (AS) ), 37 E. faecium 
(1 HLAR and 36 AS), and seven from other species (2 HLAR and 
5 AS). Sequences homologous to internal and external regions of 
IS256 as well as the central region of the aacA-aphD gene were 
amplified by PCR. Bacterial DNA from cell lysates was used as 
template. All HLAR enterococci isolates yielded aniplicons from 
both internal and external IS256 regions, whereas 10 of 36 (28%) AS 
E..faecalis, 23 of 36 (64%) AS E. faetinnz, and 5 of 5 (100%) AS from 
other species contained sequences homologous to IS256 The 
aacA-apkD gene was detected in all HLAR isolates, whereas none of 
the AS isolates contained the gene 
Conclusions: The results indicate that: (1) IS256 insertion 
sequence is strongly associated with the aacA-aphD gene, (2) the 
prevalence of IS256 in the AS enterococci isolates varies among 
different species, and (3) the presence of IS256 in AS isolates raises 
the possibility that novel IS256-based composite elements may 
emerge 
ml lnoculum effect and level of ampicillin 
resistance influence the in vitro activity of 
ampicillin plus ciprofloxacin against high-level 
gentamicin-resistant Enterococcus faecium 
M.F. Tripodi', A. Locatelli', G. Sarnataro', R. Utili'. 'Institute of 
Medical Therapy, 'Chair o f  Eopical Diseases, II University o f  Naples, 
Italy 
Objectives: A previous study demonstrated that the in vitro 
bactericidal activity of the ampicillin (AM) and ciprofloxacin (CIP) 
combination against high-level gentaniicin-resistant (HLGK) Entero- 
coccus.faecium may be influenced by the cation contents of the medium 
and the level of CIP resistance (MIC <8 mg/L) (Tripodi MF et al. 
J Antimicrob Chemother 1998; 41: 139-40). Accordingly, we studied 
the role of other factors such as inoculum size and level of AM 
resistance in the activity of AM CIP against five HLGR E.faecium 
Methods: Time-kill studies were performed in MueUer-Hinton 
Broth using two different inocula (10' and lo7 CFU/mL). Anti- 
biotics were used at serum concentrations (AM=20 mg/L; CIP= 
2 mg/L). High-level resistance to AM was obtained in a strain by 
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serial subcultures in broth containing sub-MIC concentrations of 
AM 
Results: For all strains the bactericidal activity observed with the 
lower irioculuiii was nullified with the higher one (-3.77kO.59 
versus -0.43?0.19  logic^ CFU/niL change at 24 h with respect to 
TI).  Three strains with AM MIC of 64, 128 and 256mg/L were 
obtained from the parental strain with AM MIC=32. The  activity of 
the AM CIP combination against the strain with higher AM MIC 
was lower than that observed against the parental one (- 1.37 versus 
-3.92 logl,, CFU/niL respectively) 
Conclusion: The clinical use of the AM CIP conibindtioil could 
he considered in selected cases of severe infections by HLGR 
Eiiterococcus f a e c i t i n i  provided that the strain exhibits low-level 
resistance to both agents (AM 464 mg/L and CIP <8 mg/L) and 
its susceptibility to the conibination is demonstrated in vitro using an 
appropriate inoculuni 
Resistance-epidemiology and mechanism 
m] European Antimicrobial Resistance 
Surveillance System: first results 
M.J.W. Sprenger', S.L.A.M. Bronzwaer', H. Aubry-Danioii*, 
W. Goettsch', H .  de Neeling', B. Olsson-Liljequist', M.C.J. Wale'. 
' ~ V ~ < J J I ~  Institutt, of Public Healtb a d  the Enuiroiirttenf, Bilthouen, The 
Netberlawds; 'Risenu h'afionul de S a d  Publique and National REferenie 
Cetrtrefur Awtibiofics, Paris, Frawce; .'Swedi.d~ hst i tutefur  Infe&irs 
Diseasr Corifrol, Stockbulni, Su~cdcn; 'PHLS Atitiniicrobial Susceptibility 
Surucillartce Chit  (AmSSU), CDSC Trent, Queem Medical Cetitre, 
NtJrtirqbam, ( IK 
The  European Antimicrobial Resistance Surveillance System 
(EAKSS), funded by the European Comniission (IIGV) and co- 
ol-dinated by The  Netherlands, IS an international network of 
national surveillance systems aiming to collect comparable and 
reliable antimicrobial resistance data for public health purposes. 
Taking into account laboratory methods as well as epideiinologic 
principles, EAKSS acts as an early warning systeiii, analyzes regional 
differences, assesses risk factors, and provides electronic feedback. For 
the 18-month pilot phase, microbiologists and epideniiologists from 
all E U  Meniber States, pluc Iceland, Norway, and Switzerland, will 
be collecting quantitative resistance data (MICs or Etest results in 
most cases) on Streptocticcirs pncirmoniae (SP) and Staphylococcus atireus 
(SA). For SP, isolates from blood and cerebrospinal fluid will be tested 
against penicillin G, cephalosporins and ciprotloxacin, and for SA 
from blood cultures, against niethicillin and vancomycin. Question- 
naires have been developed to collect information on laboratory 
niethods/procedurcls and catchinent population. More than 400 
laboratories will be participating by sending data via national co- 
ordinators to the centrdl EARSS database. Standardization and 
quality control methodr are being developed in consultation with 
ESCMIL) and the WHO.  Data are expected early in 1999. In 
developing the protocol and questionnaire, the challenge was to 
balance scientific validity and feasibility. A first result i s  that consensus 
has been reached by leading microbiologists and epideiiiiologists on 
the protocol m d  logistic framework. EARSS i s  already acting as a 
catalyst for national surveillance systems. 
1 086 1 Prevalence of resistance t o  MLS antibiotics in 
20 European university hospitals participating 
in the European SENTRY Antimicrobial 
Surveillance Program 
E-J. Schinitz, J. Verhoef, A. Fluit. The SENTRY Pa'articipants (3roirp, 
E(jkman- Winkler Insfitute,for M e d i d  iMicrobiolqy, litrechi, 
The Netherlands 
Objectives: To investigate the prevalence of differcnt forms of 
resistance to macrolide, lincosaniide and streptograniin (MLS) anti- 
biotics in Europe 
Methods: Antimicrobial susceptibility testing of 3653 routine 
clinical pneumococcal, staphylococcal and enterococcal isolates from 
20 European university hospitals from 12 countries. The strains were 
collected during the first year of the SENTRY Antiiii~crobial 
Surveillance Prograni (April 1997 to April 1998) 
Results: Among the 698 Strrptomciis pneumonia? isolates tested, 
72.6% were susceptible to penicillin, 21.2% were intermediate and 
6.2% were highly penicillin resistant. The combined percentages of 
penicillin-intermediate and -resistant strains varied between 0% arid 
55% Geographic differences in erythromycin and clindainycin resist- 
ance strongly reflect variations in susceptibility to penicillin. Seventy- 
eight per cent of all 1554 Staphylomrcirs atireus isolates and 42% of all 
909 CNS isolates were methicillin susceptible. In CNS the associ- 
ation between methicillin resistance and erythroniycin/clindamycin 
resistance w-as not as pronounced as for Staphy/omcrur aimiis. Elcven 
per cent of the 90 Enterococcus.faecium isolates exhibited vancomycin 
resistance, while none of the 403 E. /acralis isolates was vancomycin 
resistant. E..faecirrm isolates were less susceptible to erythroniycin than 
E. j i era l i s  isolates, while the opposite was true for clindamycin 
susceptibility. None of the Streptococcus pneumoiiiae, Sfapbylococcrts 
aweus and E. jieciunr isolates tested had an MIC of 4 mg/L for the 
streptograniin combination quinupristin/dalfopristin 
Conclusions: Geographic differences in erythromycin and 
clindaiiiycin resistance in Streptococcus ptzcwmniae and Stapbylococcus 
a i i r e u  strongly reflect the geographic variations in susceptihility to 
penicillin and methicillin in Europe, respectively 
m] Clonally related cefotaxime-resistant 
Salmonella typhimurium isolates from Greece, 
Russia and Hungary 
P.T. Tassios', M .  Gazouli', E. Tzelepi', E. Milch', N. Kozlova', 
S. Sidorenkoi, L. Tzouvelekis',', N.J. Legakis'. 'Drpartmerit ig. 
Bucteriulocqy, Hellenic Pasterrr Iiistitute, 'Dcprtutenr of Mi( robiolo'qy, 
hfdical School, (hiiuersity of Atbeus, ' h h i t ? a /  Ccriterji ir  Epideniiology, 
Greece 
Objectives: To analyze the niechanisins of resistance to newer 
cephalosporins of Salnioriella tyjdiimirriirin from Greece, Russia and 
Hungary, a i d  deterrnme the genetic relationships of cephalosporin- 
resistant strains 
Methods: Two cefotaxiiiie-resistant S. fypbimriritrin strains from 
Greece, eight froin Russia and three from Hungary were studied. 
They were identified by API20E and 0- and H-antisera. Sus- 
ceptibility to antibiotics was determined by an agar dilution method. 
Resistance determinants were transferred by conjugation and tranr- 
formation. Plasmids were extracted by alkaline lysis. b-Lactaniase 
content was analyzed by isoelectric focusing (IEF). Units of b- 
lactamase activity were determined using nitrocefin. Substrate and 
inhibition profiles of the b-lactaniase preparations were obtained by 
spectrophotonietry. b-Lactaiiiase genes wcre cloned in the p K S K  
phagemid and the nucleotide sequences were determined by the 
